Insider Trading Alert - PRE, NNN And LLY Traded By Insiders
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.
Yesterday, March 24, 2015, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $380.00 to $19,195,500.00.
Highlighted Stocks Traded by Insiders:
PartnerRe (PRE) - FREE Research Report
Miranthis Constantinos, who is Former President & CEO at PartnerRe, sold 10,000 shares at $112.93 on March 24, 2015. Following this transaction, the Former President & CEO owned 135,427 shares meaning that the stake was reduced by 6.88% with the 10,000-share transaction.
The shares most recently traded at $112.14, down $0.79, or 0.7% since the insider transaction. Historical insider transactions for PartnerRe go as follows:
- 4-Week # shares sold: 62,768
- 12-Week # shares sold: 62,768
- 24-Week # shares sold: 63,768
The average volume for PartnerRe has been 506,800 shares per day over the past 30 days. PartnerRe has a market cap of $5.3 billion and is part of the financial sector and insurance industry. Shares are down 2.14% year-to-date as of the close of trading on Tuesday.
PartnerRe Ltd., through its subsidiaries, provides reinsurance and certain specialty insurance services worldwide. It operates in three segments: Non-life, Life and Health, and Corporate and Other. The stock currently has a dividend yield of 2.48%. The company has a P/E ratio of 5.8. Currently, there are 2 analysts who rate PartnerRe a buy, 1 analyst rates it a sell, and 11 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on PRE - FREE
rates PartnerRe as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, attractive valuation levels and increase in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
National Retail Properties (NNN) - FREE Research Report
Habicht Kevin B, who is Evp & Cfo at National Retail Properties, sold 21,633 shares at $41.99 on March 24, 2015. Following this transaction, the Evp & Cfo owned 174,472 shares meaning that the stake was reduced by 11.03% with the 21,633-share transaction.
Tessitore Christopher Paul, who is Executive Officer at National Retail Properties, sold 5,000 shares at $42.66 on March 24, 2015. Following this transaction, the Executive Officer owned 114,889 shares meaning that the stake was reduced by 4.17% with the 5,000-share transaction.
The shares most recently traded at $41.73, down $0.93, or 2.23% since the insider transaction. Historical insider transactions for National Retail Properties go as follows:
- 4-Week # shares sold: 75,129
- 12-Week # shares sold: 112,739
- 24-Week # shares sold: 112,739
The average volume for National Retail Properties has been 1.2 million shares per day over the past 30 days. National Retail Properties has a market cap of $5.6 billion and is part of the financial sector and real estate industry. Shares are up 5.66% year-to-date as of the close of trading on Tuesday.
National Retail Properties, Inc. is a publicly owned equity real estate investment trust. The firm acquires, owns, manages, and develops retail properties in the United States. The stock currently has a dividend yield of 3.98%. The company has a P/E ratio of 34.0. Currently, there are 5 analysts who rate National Retail Properties a buy, 2 analysts rate it a sell, and 5 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on NNN - FREE
rates National Retail Properties as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins, good cash flow from operations and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full
National Retail Properties Ratings Report
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Eli Lilly and (LLY) - FREE Research Report
Lilly Endowment Inc, who is 10% Owner at Eli Lilly and, sold 190,000 shares at $76.97 on March 24, 2015. Following this transaction, the 10% Owner owned 131.2 million shares meaning that the stake was reduced by 0.14% with the 190,000-share transaction.
The shares most recently traded at $75.78, down $1.19, or 1.57% since the insider transaction. Historical insider transactions for Eli Lilly and go as follows:
- 4-Week # shares bought: 17,157
- 4-Week # shares sold: 4,000
- 12-Week # shares bought: 17,157
- 12-Week # shares sold: 134,548
- 24-Week # shares bought: 17,157
- 24-Week # shares sold: 1.3 million
The average volume for Eli Lilly and has been 4.5 million shares per day over the past 30 days. Eli Lilly and has a market cap of $84.8 billion and is part of the health care sector and drugs industry. Shares are up 9.52% year-to-date as of the close of trading on Tuesday.
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The stock currently has a dividend yield of 2.62%. The company has a P/E ratio of 34.2. Currently, there are 6 analysts who rate Eli Lilly and a buy, no analysts rate it a sell, and 9 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on LLY - FREE
rates Eli Lilly and as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
null